KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Clover Health Investments (CLOV) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for Clover Health Investments (CLOV) over the last 6 years, with Q3 2025 value amounting to $423.5 million.

  • Clover Health Investments' Cost of Revenue rose 6954.25% to $423.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 3799.6%. This contributed to the annual value of $1.0 billion for FY2024, which is 17.29% up from last year.
  • Per Clover Health Investments' latest filing, its Cost of Revenue stood at $423.5 million for Q3 2025, which was up 6954.25% from $378.0 million recorded in Q2 2025.
  • Clover Health Investments' Cost of Revenue's 5-year high stood at $861.7 million during Q1 2022, with a 5-year trough of -$1.6 billion in Q4 2022.
  • Moreover, its 5-year median value for Cost of Revenue was $274.8 million (2023), whereas its average is $300.5 million.
  • Data for Clover Health Investments' Cost of Revenue shows a peak YoY increase of 30188.51% (in 2022) and a maximum YoY decrease of 45463.4% (in 2022) over the last 5 years.
  • Over the past 5 years, Clover Health Investments' Cost of Revenue (Quarter) stood at $441.9 million in 2021, then tumbled by 454.63% to -$1.6 billion in 2022, then surged by 115.94% to $249.8 million in 2023, then decreased by 2.69% to $243.0 million in 2024, then surged by 74.24% to $423.5 million in 2025.
  • Its Cost of Revenue was $423.5 million in Q3 2025, compared to $378.0 million in Q2 2025 and $353.4 million in Q1 2025.